Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs Telomir Pharmaceuticals, Inc. (TELO)

Champions Oncology, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Champions Oncology, Inc. is the larger, with a market value of $66.3M against $57.5M — 1.2× the size. Telomir Pharmaceuticals, Inc. has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (0.00% vs −626.2%). Across the 13 metrics below, Telomir Pharmaceuticals, Inc. leads on 7 and Champions Oncology, Inc. on 6.

Valuation

Metric CSBR TELO Biotechnology median
P/E n/m n/m 10.26
P/S 1.10 n/m 9.18
P/B 14.93 9.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 200.35 n/m 0.65
EV/Sales 1.03 n/m 8.98
Earnings yield (1.67%) (116.67%) (34.89%)
Free cash flow yield (9.18%) (10.36%) (24.52%)

Profitability

Metric CSBR TELO Biotechnology median
Gross margin 49.82% — 65.16%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) (1,885.50%) (50.12%)
Return on assets (3.56%) (1,678.31%) (45.60%)
Return on invested capital (626.23%) 0.00% 0.00%

Growth

Metric CSBR TELO Biotechnology median
Revenue growth (TTM) 6.65% — 6.26%
EPS growth (last fiscal year) (124.24%) 41.07% 29.88%
Revenue growth, 5-year CAGR 7.68% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CSBR TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 1.03 16.14 4.89
Net debt to EBITDA (20.56) 0.69 1.01

Dividend

Metric CSBR TELO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CSBR TELO Biotechnology median
Market cap 66.26m 57.48m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack